Could a simple oil boost brain health in early psychosis?
NCT ID NCT07122531
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a medium-chain triglyceride (MCT) oil supplement, which raises ketone levels, can improve metabolism and symptoms in 15 young adults with first-episode psychosis. Participants take the supplement twice daily for 12 weeks alongside their usual antipsychotic medication. The goal is to see if it is safe, tolerable, and helps with blood sugar control and mental health symptoms.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FIRST EPISODE PSYCHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hotel-Dieu CIUSSS de l'Estrie-CHUS
RECRUITINGSherbrooke, Quebec, J1H 4C4, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a tailored therapy help young people overcome the stigma of psychosis?
- Your phone could help doctors prescribe better: app tracks symptoms in real time
- Can mindfulness ease psychosis in teens and young adults?
- Can a text message get at-risk youth into psychosis care faster?
- Texts and apps could help at-risk youth seek psychosis care earlier
- New program aims to help young people recover from first psychotic episodes